An overview on the Balloon Catheter Market (2023 to 2033)
The global balloon catheter demand is subjected to growth at a CAGR of 4.3%. The market revenue is likely to be valued at US$ 4.2 Billion in 2023 and exhibit a revenue growth of US$ 6.4 Billion by 2033.
Key players aim at providing balloon catheter technologies that offer the excellent performance required to succeed in difficult circumstances. Furthermore, their exclusive laser-bonded method produces an exceptional TrakTipTM design as well as accurate, smooth bonding along the shaft. These also provide occlusion balloon catheters, which are particularly intended to minimize stone fragment movement down the ureter during PCNL treatments.
Mustang, created by a specific market player, improves patient outcomes because of its reduced sheath diameters. Mustang is meant to facilitate and speed up the operation by having superior cross and track, forceful dilatation, and longer lengths.
To ease strictures and allow the implantation of bigger surgical tools, consumers may always employ a balloon dilatation catheter developed for radial dilatation of the urinary tract. Furthermore, when reaching distant lesions in tiny veins below the knee, end users prefer PTA quick exchange balloon dilatation catheter.
Clinicians may also use the chameleon balloon catheter, which combines the functions of a high-pressure balloon catheter with a diagnostic catheter - allowing for the proximal administration of diagnostic fluids (such as contrast media) and therapeutic fluids. Key companies provide a comprehensive coronary portfolio that includes effective lesion preparation and treatment options. Their next-generation stents and balloon catheters enable polymer-free medication delivery for better clinical outcomes.
Over the previous 12 years, the product family presented by the majority of market participants has proven its functionality and efficacy for coronary lesion treatment, as evidenced by a substantial clinical evidence portfolio comprising more than 110 published studies. A market player recently introduced a next-generation balloon dilatation catheter with high-pressure capacity. It is intended to improve the treatment of patients with coronary artery disease (CAD) during angioplasty treatments.
The product is presently accessible in the United States, Europe, and a few Asian and Latin American countries. The novel method is suitable for both pre-and post-dilatation treatments. VOYAGER NC can be used by physicians to negotiate convoluted anatomy and open up lesions before delivering a stent, or to expand a stent more precisely against the arterial wall once it has been implanted.
Balloon catheters introduced by the key players are designed for stent post- and pre-dilatation of refractory lesions. They also have limited compliance and longitudinal balloon expansion. It is solely employed to dilate the stenotic segment of a coronary artery with a balloon. Moreover, it may be used to bypass graft stenosis to improve myocardial perfusion and for post-dilatation of coronary stents. Some key players have been successful in domestically producing an IABP (Intra-Aortic Balloon Pumping) balloon catheter, a first-aid device for myocardial infarction. They continue to outperform their competitors in the high-tech medical industry.
Attributes
Details
Balloon Catheter Market HCAGR (2017 to 2022)
3.6%
Balloon Catheter Market CAGR (2023 to 2033)
4.3%
Market Size for Balloon Catheter (2023)
US$ 4.2 Billion
Market Size for Balloon Catheter (2033)
US$ 6.4 Billion
According to the World Health Organization (WHO) (2021), cardiovascular disease (CVD) is the leading cause of mortality globally, accounting for an estimated 17.9 Million deaths per year. Similarly, rising demand for minimally invasive operations, as well as an increase in the number of catheterization labs across the area, are likely to drive profitable growth during the projection period.
The majority of cardiovascular problems are treated with treatments such as percutaneous transluminal coronary angioplasty (PTCA), which makes heavy use of PTCA balloon catheters. As a result of the rising frequency of cardiovascular illnesses, a greater number of PCI operations are predicted to be performed. This is expected to create new balloon catheter market trends.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
A Contrast with the Historical Market Scenario:
According to the data compiled by Future Market Insights, the global forum of balloon catheters has experienced an exceptional growth in recent years. The market's leading providers are working in tandem with the growing demand for balloon catheters. The CAGR rate from 2017 to 2022 was 3.6%, and it is expected to increase to 4.3% during the forecast period.
Comparative Analysis of Adjacent Markets:
Balloon Catheter Market:
Attributes
Balloon Catheter Market
CAGR (2023 to 2033)
4.3%
Market Value (2033)
US$ 6.4 Billion
Growth Factor
Interventional cardiology is gaining popularity, which is pushing the use of modern balloon catheters such as drug-eluting balloon catheters.
Opportunity
The rising frequency of CAD and the growth in angioplasty patients are anticipated to drive the demand for balloon catheters.
Restraints
The high cost of such premium items might be challenging for middle and low-income countries to embrace them. This might impede the market expansion.
Micro Balloon Catheter Market:
Attributes
Micro Balloon Catheter Market
CAGR (2023 to 2033)
3.4%
Market Value (2033)
US$ 295.8 Million
Growth Factor
The increased frequency of cardiovascular illnesses and the expanding geriatric population.
Opportunity
Various reasons, such as increased expenditure in research and development efforts for micro balloon catheters, are projected to increase the demand for this product.
Restraints
The expenses of angioplasty operations are high in cost, especially combined with the risk of arterial collapse and infection associated with balloon catheterization.
Stent Graft Balloon Catheter Market:
Attributes
Stent Graft Balloon Catheter Market
CAGR (2023 to 2033)
7%
Market Value (2033)
US$ 1,928 Million
Growth Factor
Increased healthcare spending and infrastructural improvements in developing economies.
Opportunity
Initiatives by governments and non-governmental organizations to improve awareness about cardiovascular diseases are projected to boost the market growth.
Restraints
The high cost of angioplasty procedures, along with a shortage of qualified doctors, are hindering the market growth.
Find your sweet spots for generating winning opportunities in this market.
Category-wise Insights:
Nylon - By Raw Material
By raw material type, the market is segmented into polyurethane, nylon, and others. The nylon sector is likely to have a large market share of 4.2% throughout the forecast period, according to Future Market Insights researchers.
The essential elements determining the velocity of this segment are:
Since nylon high-pressure balloons require a thicker wall for a given burst pressure, they have a broader profile than identical PET balloons when inserted into the body and bridging a lesion.
Owing to their qualities when inflated by volume, they may stretch 100% to 800% and are frequently utilized in applications that need the balloon to totally conform to or occlude the anatomy.
Coronary Artery Disease - By Indication Type
Based on indication, the market is segmented into coronary artery disease and peripheral vascular disease. According to Future Market Insights analysts, the coronary artery disease sector is expected to have a larger market share throughout the forecast period and may require the most balloon catheters.
The critical aspects driving the progression of this segment are:
According to World Health Organization (WHO) figures from 2017, coronary artery disease (CAD) is the most common kind of heart disease.
The World Health Organization (WHO) has also claimed that cardiovascular problems account for the bulk of non-communicable disease mortality.
How does the Product Recall Restrain Market Growth?
In the United States, balloon catheters are controlled by the Food and Drug Administration (FDA). The Food and Drug Administration and the United States agency in charge of medical device regulation give guidance on requirements for specific Class II applications. Consequently, the FDA's product recall is projected to hamper the market growth.
Region-Wise Overview:
Country
The United States
CAGR (2023 to 2033)
4.2%
HCAGR (2017 to 2022)
3.5%
Country
The United Kingdom
CAGR (2023 to 2033)
4.8%
HCAGR (2017 to 2022)
5.5%
Country
Germany
CAGR (2023 to 2033)
4.7%
HCAGR (2017 to 2022)
5.3%
Country
China
CAGR (2023 to 2033)
4.8%
HCAGR (2017 to 2022)
4.2%
Country
India
CAGR (2023 to 2033)
5.6%
HCAGR (2017 to 2022)
5.3%
Low-profile Cross-ability with Proven Clinical Effectiveness - The USA Market Players Transcending!
Attributes
Details
USA Market Size (2033)
US$ 1.6 Billion
USA Market Absolute Dollar Growth (US$ Million/Billion)
US$ 534.8 Million
North America is a significant balloon catheter market, particularly in the USA, which holds a revenue share of 4.2%. The value of the balloon catheter market in the USA is estimated to reach a high of US$ 1.6 Billion. This is attributed to the availability of modern healthcare facilities and infrastructure, healthcare spending, and increased patient awareness.
In the United States, consumers choose balloon catheters with low-profile cross-ability and proven clinical effectiveness in crossing stent struts and bifurcations. Furthermore, significant companies provide balloon catheters with innovative shaft and tip technology, as well as an extended-size matrix that improves the balance of trackability and pushability. The key market driver is the number of percutaneous coronary intervention (PCI) operations since a slight drop in the average selling price of devices is projected.
Purity, Symmetry, and Robustness: The Mantra of Balloon Catheter Providers in the United Kingdom!
Attributes
Details
The United Kingdom Market Size (2033)
US$ 273.4 Million
The United Kingdom Market Absolute Dollar Growth (US$ Million/Billion)
US$ 102.7 Million
Diabetes prevalence, government efforts, and the release of various technologically improved products by key manufacturers are anticipated to propel the balloon catheter market share in Europe, especially in the United Kingdom and Germany. The United Kingdom produces notable market potential, with a high-paced revenue growth rate of 4.8% and an anticipated value of US$ 273.4 Million, throughout the projection period.
The United Kingdom has a considerable global market share among world-leading providers of high-quality balloon catheters. Their balloon catheters are exceptional in terms of purity, symmetry, and robustness, which are critical for certain medical device applications. Key players in the United Kingdom provide a variety of balloon catheters particularly developed to stop severe posterior nasal bleeding (epistaxis) that cannot be stopped by conventional means. They aspire to advance the area of stroke care via continual, deliberate innovation that yields real results. This is accomplished by focusing on the advancement of less invasive stroke therapeutics.
Germany - Home to the Modern Drug-eluting Balloon Technology!
Attributes
Details
Germany Market Size (2033)
US$ 244.3 Million
Germany Market Absolute Dollar Growth (US$ Million/Billion)
US$ 89.8 Million
Germany is a lucrative balloon catheter market, growing at a profit of 4.7%. The value of the balloon catheter market in Germany is expected to reach a high of US$ 244.3 Million. Germany is home to the most recent generation of drug-eluting balloon technology, which is meant to provide the same level of safety and performance as the best-in-class DES technology.
The core products offered by the key clinicians include stents (balloon-expandable and self-expandable), balloons for coronary and peripheral applications, catheters, and a wide variety of interventional cardiology and radiology accessories. Moreover, they provide components for the medical industry, such as specific tubes and sticky adhesives. They also provide a product search service, which includes the procurement of specialty items.
Key companies provide equipment designed exclusively for use as a Percutaneous Transluminal Coronary Angioplasty (PTCA) balloon catheter to dilate de novo or restenosis coronary lesions for improving myocardial perfusion and reducing the incidence of restenosis. Furthermore, they provide the most comprehensive selection of PTCA drug-eluting balloon catheters, with balloon diameters ranging from 1.50 mm to 5.00 mm and lengths ranging from 10 mm to 40 mm.
Most key companies establish customer value through their lean organizational structure as medium-sized businesses. As a consequence, response times are reduced, unique client demands are met, and costs are reduced. Hence, they provide German-quality items at extremely reasonable pricing. Their goal is to strengthen the long-term ties with their customers and increase long-term collaborations.
In China, the Balloon Technology is Widely Known for Innovation - Advanced Technological Solutions.
Attributes
Details
China Market Size (2033)
US$ 413.9 Million
China Market Absolute Dollar Growth (US$ Million/Billion)
US$ 154.6 Million
China controls a sizable portion of the balloon catheter market, accounting for 4.8% of total sales. The balloon catheter market in China is expected to reach a peak of US$ 413.9 Million. A few key players claim that the original members of their team are seasoned field professionals from China and the United States.
Their current core teams reputedly have more than a decade of field experience. Key players provide balloon catheters that combine their balloon tubing with 'Earnan Balloon Technology,' which is widely known for innovation and advanced technological solutions. They have pioneered additive manufacturing methods, employing unique techniques and medical-grade materials to produce components with complicated tolerances, geometries, and features.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Newbies are Catching Up with Key Players with Innovative Strategies: Start-up Economy
tart-up companies have introduced advanced technologies to supply premium balloon catheters. This is expected to contribute to the global balloon catheter market growth:
MicroPort CardioFlow Medtech Corporation - It creates sophisticated medical gadgets for individuals suffering from heart valve disorders. VitaFlow, a transcatheter aortic valve implantation device created by the business, aids in the treatment of aortic valve stenosis condition in the elderly. It also includes an Alwide Aoguang valve balloon dilatation catheter for surgical aortic valve replacement, as well as an Alpass Ao Shun catheter sheath kit and other items.
Gmeditech - It is the creator of a 3D surgical navigation device and balloon catheter fusion method. It created a fusion system that consists of a 3D surgical navigation device and a balloon catheter with a matching degree of 1mm and an internal pressure of 13atm. It is a hybrid surgical navigation system with electromagnetic and optical positioning. The location-tracking balloon catheter monitors the specific position in the body to verify the entrance of the surgical target, such as the frontal sinus, sphenoid sinus, or maxillary sinus, so that balloon dilatation may be conducted at the proper spot.
PuChuang - It is a platform for cardiac and vascular intervention technology development. Sonico is an intravascular shock wave balloon catheter system designed to treat arterial vascular calcification.
Key Companies Revamping the Balloon Catheter Market
The presence of a significant number of prominent players in various regions contributes to the market growth hugely. Ongoing Research and Development (R&D) operations to develop improved technologies, as well as new product innovation provide more potential for the balloon catheter market share.
Novel Developments:
In 2020, The Opticross 35 imaging catheter for peripheral imaging was introduced by Boston Scientific Corporation. With a larger IVUS depth and 360-degree clear image quality, this device offers depth and diversity to the company's wide product offering.
In 2021, Medtronic PLC has added a new type of catheter to its arsenal: a balloon catheter capable of eluting medications at the site of administration. In the European market for CAD, this device is called the Prevail Drug-Coated Balloon, and it increases the catheter's pushability and its deliverability into complicated anatomies. The medicine on the balloon is absorbed into the target artery tissue, reducing the possibility of in-stent restenosis.
In April 2019, The UltraScore 014 focused force percutaneous transluminal angioplasty (PTA) balloon was introduced by Becton, Dickinson, and Company. The UltraScore balloon is designed to dilate stenoses in the iliac, femoral, iliofemoral, popliteal, infra-popliteal, and renal arteries and to treat obstructive lesions in native or synthetic arteriovenous dialysis fistulas.
In May 2019, The Advance Enforcer 35 Focal Force PTA balloon catheter was recalled by Cook Medical owing to the balloon bursting below the rated burst pressure.
TOP MARKET PLAYERS OF THE BALLOON CATHETER MARKET:
Boston Scientific Inc.
Medtronic
Terumo Corporation
B. Braun Melsungen AG
MicroPort Scientific Corporation
Jotech GmbH
QX Medical LLC
Meril Life Pvt. Ltd.
Hexacath
Abbott Laboratories
Tokai Medical Products Inc.
Biosensors International Ltd.
Cook Medical Inc.
Cardionovum GmbH.
Cordis Corporation
Biotronik
Nitinol Device & Components Inc.
Key Segments Profiled in the Balloon Catheter Market Survey
By Product Type:
Normal
Cutting
Scoring
Drug Eluting
Others
By Raw Material:
Polyurethane
Nylon
Others
By Indication:
Coronary Artery Disease
Peripheral Vascular Disease
By End User:
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratories
By Region:
North America
Latin America
Asia Pacific
MEA
Europe
Frequently Asked Questions
The market is valued at US$ 4.2 billion in 2023.
The market is estimated to record a CAGR of 4.3% through 2033.
Boston Scientific Inc., Medtronic, and Terumo Corporation are the key market players.
The rise in the number of angioplasty patients is to boost the market prospects.
The nylon segment is likely to remain preferred through 2033.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Analysis 2017 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ million) & Volume (Units) Analysis, 2017 to 2022
4.2. Current and Future Market Size Value (US$ million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Product, 2017 to 2022
5.3. Current and Future Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033
5.3.1. Normal Balloon Catheter
5.3.2. Cutting Balloon Catheter
5.3.3. Scoring Balloon Catheter
5.3.4. Drug Eluting Balloon Catheter
5.3.5. Stent Graft Balloon Catheter
5.4. Y-o-Y Growth Trend Analysis By Product, 2017 to 2022
5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
6. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Raw Material
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Raw Material, 2017 to 2022
6.3. Current and Future Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Raw Material, 2023 to 2033
6.3.1. Polyurethane
6.3.2. Nylon
6.3.3. Others
6.4. Y-o-Y Growth Trend Analysis By Raw Material, 2017 to 2022
6.5. Absolute $ Opportunity Analysis By Raw Material, 2023 to 2033
7. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Indication
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Indication, 2017 to 2022
7.3. Current and Future Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Indication, 2023 to 2033
7.3.1. Coronary Artery Disease
7.3.2. Peripheral Vascular Disease
7.4. Y-o-Y Growth Trend Analysis By Indication, 2017 to 2022
7.5. Absolute $ Opportunity Analysis By Indication, 2023 to 2033
8. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By End User, 2017 to 2022
8.3. Current and Future Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033
8.3.1. Hospitals
8.3.1.1. Private Hospitals
8.3.1.2. Public Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Cardiac Catheterization Laboratories
8.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2022
8.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
9. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Region, 2017 to 2022
9.3. Current Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
9.3.1. North America
9.3.2. Latin America
9.3.3. Eastern Europe
9.3.4. Western Europe
9.3.5. Asia Pacific excluding Japan (APEJ)
9.3.6. Japan
9.3.7. MEA
9.4. Market Attractiveness Analysis By Region
10. North America Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
10.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. The USA
10.2.1.2. Canada
10.2.2. By Product
10.2.3. By Raw Material
10.2.4. By Indication
10.2.5. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By Raw Material
10.3.4. By Indication
10.3.5. By End User
10.4. Key Takeaways
11. Latin America Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
11.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Product
11.2.3. By Raw Material
11.2.4. By Indication
11.2.5. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By Raw Material
11.3.4. By Indication
11.3.5. By End User
11.4. Key Takeaways
12. Eastern Europe Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
12.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Rest of Eastern Europe
12.2.2. By Product
12.2.3. By Raw Material
12.2.4. By Indication
12.2.5. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Raw Material
12.3.4. By Indication
12.3.5. By End User
12.4. Key Takeaways
13. Western Europe Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
13.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. Germany
13.2.1.2. U.K.
13.2.1.3. France
13.2.1.4. Spain
13.2.1.5. Italy
13.2.1.6. Rest of Western Europe
13.2.2. By Product
13.2.3. By Raw Material
13.2.4. By Indication
13.2.5. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Raw Material
13.3.4. By Indication
13.3.5. By End User
13.4. Key Takeaways
14. APEJ Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
14.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. India
14.2.1.3. A&NZ
14.2.1.4. Rest of APEJ
14.2.2. By Product
14.2.3. By Raw Material
14.2.4. By Indication
14.2.5. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By Raw Material
14.3.4. By Indication
14.3.5. By End User
14.4. Key Takeaways
15. Japan Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
15.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.2. By Product
15.2.3. By Raw Material
15.2.4. By Indication
15.2.5. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product
15.3.3. By Raw Material
15.3.4. By Indication
15.3.5. By End User
15.4. Key Takeaways
16. MEA Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
16.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
16.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
16.2.1. By Country
16.2.1.1. GCC Countries
16.2.1.2. South Africa
16.2.1.3. Rest of MEA
16.2.2. By Product
16.2.3. By Raw Material
16.2.4. By Indication
16.2.5. By End User
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Product
16.3.3. By Raw Material
16.3.4. By Indication
16.3.5. By End User
16.4. Key Takeaways
17. Key Countries Analysis
17.1. The USA
17.1.1. Pricing Analysis
17.1.2. Market Share Analysis, 2022
17.1.2.1. By Product
17.1.2.2. By Raw Material
17.1.2.3. By Indication
17.1.2.4. By End User
17.2. Canada
17.2.1. Pricing Analysis
17.2.2. Market Share Analysis, 2022
17.2.2.1. By Product
17.2.2.2. By Raw Material
17.2.2.3. By Indication
17.2.2.4. By End User
17.3. Brazil
17.3.1. Pricing Analysis
17.3.2. Market Share Analysis, 2022
17.3.2.1. By Product
17.3.2.2. By Raw Material
17.3.2.3. By Indication
17.3.2.4. By End User
17.4. Mexico
17.4.1. Pricing Analysis
17.4.2. Market Share Analysis, 2022
17.4.2.1. By Product
17.4.2.2. By Raw Material
17.4.2.3. By Indication
17.4.2.4. By End User
17.5. Poland
17.5.1. Pricing Analysis
17.5.2. Market Share Analysis, 2022
17.5.2.1. By Product
17.5.2.2. By Raw Material
17.5.2.3. By Indication
17.5.2.4. By End User
17.6. Russia
17.6.1. Pricing Analysis
17.6.2. Market Share Analysis, 2022
17.6.2.1. By Product
17.6.2.2. By Raw Material
17.6.2.3. By Indication
17.6.2.4. By End User
17.7. Germany
17.7.1. Pricing Analysis
17.7.2. Market Share Analysis, 2022
17.7.2.1. By Product
17.7.2.2. By Raw Material
17.7.2.3. By Indication
17.7.2.4. By End User
17.8. U.K.
17.8.1. Pricing Analysis
17.8.2. Market Share Analysis, 2022
17.8.2.1. By Product
17.8.2.2. By Raw Material
17.8.2.3. By Indication
17.8.2.4. By End User
17.9. France
17.9.1. Pricing Analysis
17.9.2. Market Share Analysis, 2022
17.9.2.1. By Product
17.9.2.2. By Raw Material
17.9.2.3. By Indication
17.9.2.4. By End User
17.10. Spain
17.10.1. Pricing Analysis
17.10.2. Market Share Analysis, 2022
17.10.2.1. By Product
17.10.2.2. By Raw Material
17.10.2.3. By Indication
17.10.2.4. By End User
17.11. Italy
17.11.1. Pricing Analysis
17.11.2. Market Share Analysis, 2022
17.11.2.1. By Product
17.11.2.2. By Raw Material
17.11.2.3. By Indication
17.11.2.4. By End User
17.12. China
17.12.1. Pricing Analysis
17.12.2. Market Share Analysis, 2022
17.12.2.1. By Product
17.12.2.2. By Raw Material
17.12.2.3. By Indication
17.12.2.4. By End User
17.13. India
17.13.1. Pricing Analysis
17.13.2. Market Share Analysis, 2022
17.13.2.1. By Product
17.13.2.2. By Raw Material
17.13.2.3. By Indication
17.13.2.4. By End User
17.14. A&NZ
17.14.1. Pricing Analysis
17.14.2. Market Share Analysis, 2022
17.14.2.1. By Product
17.14.2.2. By Raw Material
17.14.2.3. By Indication
17.14.2.4. By End User
17.15. Japan
17.15.1. Pricing Analysis
17.15.2. Market Share Analysis, 2022
17.15.2.1. By Product
17.15.2.2. By Raw Material
17.15.2.3. By Indication
17.15.2.4. By End User
17.16. GCC Countries
17.16.1. Pricing Analysis
17.16.2. Market Share Analysis, 2022
17.16.2.1. By Product
17.16.2.2. By Raw Material
17.16.2.3. By Indication
17.16.2.4. By End User
17.17. South Africa
17.17.1. Pricing Analysis
17.17.2. Market Share Analysis, 2022
17.17.2.1. By Product
17.17.2.2. By Raw Material
17.17.2.3. By Indication
17.17.2.4. By End User
18. Market Structure Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Market Share Analysis of Top Players
18.3.1. By Regional
18.3.2. By Product
18.3.3. By Raw Material
18.3.4. By Indication
18.3.5. By End User
19. Competition Analysis
19.1. Competition Deep Dive
19.1.1. Boston Scientific Inc.
19.1.1.1. Overview
19.1.1.2. Product Portfolio
19.1.1.3. Profitability by Market Segments
19.1.1.4. Sales Footprint
19.1.1.5. Strategy Overview
19.1.1.5.1. Marketing Strategy
19.1.1.5.2. Product Strategy
19.1.1.5.3. Channel Strategy
19.1.2. Medtronic
19.1.2.1. Overview
19.1.2.2. Product Portfolio
19.1.2.3. Profitability by Market Segments
19.1.2.4. Sales Footprint
19.1.2.5. Strategy Overview
19.1.2.5.1. Marketing Strategy
19.1.2.5.2. Product Strategy
19.1.2.5.3. Channel Strategy
19.1.3. Terumo Corporation
19.1.3.1. Overview
19.1.3.2. Product Portfolio
19.1.3.3. Profitability by Market Segments
19.1.3.4. Sales Footprint
19.1.3.5. Strategy Overview
19.1.3.5.1. Marketing Strategy
19.1.3.5.2. Product Strategy
19.1.3.5.3. Channel Strategy
19.1.4. B. Braun Melsungen AG
19.1.4.1. Overview
19.1.4.2. Product Portfolio
19.1.4.3. Profitability by Market Segments
19.1.4.4. Sales Footprint
19.1.4.5. Strategy Overview
19.1.4.5.1. Marketing Strategy
19.1.4.5.2. Product Strategy
19.1.4.5.3. Channel Strategy
19.1.5. MicroPort Scientific Corporation
19.1.5.1. Overview
19.1.5.2. Product Portfolio
19.1.5.3. Profitability by Market Segments
19.1.5.4. Sales Footprint
19.1.5.5. Strategy Overview
19.1.5.5.1. Marketing Strategy
19.1.5.5.2. Product Strategy
19.1.5.5.3. Channel Strategy
19.1.6. Jotech GmbH
19.1.6.1. Overview
19.1.6.2. Product Portfolio
19.1.6.3. Profitability by Market Segments
19.1.6.4. Sales Footprint
19.1.6.5. Strategy Overview
19.1.6.5.1. Marketing Strategy
19.1.6.5.2. Product Strategy
19.1.6.5.3. Channel Strategy
19.1.7. QX Medical LLC
19.1.7.1. Overview
19.1.7.2. Product Portfolio
19.1.7.3. Profitability by Market Segments
19.1.7.4. Sales Footprint
19.1.7.5. Strategy Overview
19.1.7.5.1. Marketing Strategy
19.1.7.5.2. Product Strategy
19.1.7.5.3. Channel Strategy
19.1.8. Meril Life Pvt. Ltd
19.1.8.1. Overview
19.1.8.2. Product Portfolio
19.1.8.3. Profitability by Market Segments
19.1.8.4. Sales Footprint
19.1.8.5. Strategy Overview
19.1.8.5.1. Marketing Strategy
19.1.8.5.2. Product Strategy
19.1.8.5.3. Channel Strategy
19.1.9. Hexacath
19.1.9.1. Overview
19.1.9.2. Product Portfolio
19.1.9.3. Profitability by Market Segments
19.1.9.4. Sales Footprint
19.1.9.5. Strategy Overview
19.1.9.5.1. Marketing Strategy
19.1.9.5.2. Product Strategy
19.1.9.5.3. Channel Strategy
19.1.10. Abbott Laboratories
19.1.10.1. Overview
19.1.10.2. Product Portfolio
19.1.10.3. Profitability by Market Segments
19.1.10.4. Sales Footprint
19.1.10.5. Strategy Overview
19.1.10.5.1. Marketing Strategy
19.1.10.5.2. Product Strategy
19.1.10.5.3. Channel Strategy
19.1.11. Tokai Medical Products Inc
19.1.11.1. Overview
19.1.11.2. Product Portfolio
19.1.11.3. Profitability by Market Segments
19.1.11.4. Sales Footprint
19.1.11.5. Strategy Overview
19.1.11.5.1. Marketing Strategy
19.1.11.5.2. Product Strategy
19.1.11.5.3. Channel Strategy
19.1.12. Biosensors International Ltd.
19.1.12.1. Overview
19.1.12.2. Product Portfolio
19.1.12.3. Profitability by Market Segments
19.1.12.4. Sales Footprint
19.1.12.5. Strategy Overview
19.1.12.5.1. Marketing Strategy
19.1.12.5.2. Product Strategy
19.1.12.5.3. Channel Strategy
19.1.13. Cook Medical Inc.
19.1.13.1. Overview
19.1.13.2. Product Portfolio
19.1.13.3. Profitability by Market Segments
19.1.13.4. Sales Footprint
19.1.13.5. Strategy Overview
19.1.13.5.1. Marketing Strategy
19.1.13.5.2. Product Strategy
19.1.13.5.3. Channel Strategy
19.1.14. Cardionovum GmbH.
19.1.14.1. Overview
19.1.14.2. Product Portfolio
19.1.14.3. Profitability by Market Segments
19.1.14.4. Sales Footprint
19.1.14.5. Strategy Overview
19.1.14.5.1. Marketing Strategy
19.1.14.5.2. Product Strategy
19.1.14.5.3. Channel Strategy
19.1.15. Cordis Corporation
19.1.15.1. Overview
19.1.15.2. Product Portfolio
19.1.15.3. Profitability by Market Segments
19.1.15.4. Sales Footprint
19.1.15.5. Strategy Overview
19.1.15.5.1. Marketing Strategy
19.1.15.5.2. Product Strategy
19.1.15.5.3. Channel Strategy
19.1.16. Biotronik
19.1.16.1. Overview
19.1.16.2. Product Portfolio
19.1.16.3. Profitability by Market Segments
19.1.16.4. Sales Footprint
19.1.16.5. Strategy Overview
19.1.16.5.1. Marketing Strategy
19.1.16.5.2. Product Strategy
19.1.16.5.3. Channel Strategy
19.1.17. Nitinol Device & Components Inc.
19.1.17.1. Overview
19.1.17.2. Product Portfolio
19.1.17.3. Profitability by Market Segments
19.1.17.4. Sales Footprint
19.1.17.5. Strategy Overview
19.1.17.5.1. Marketing Strategy
19.1.17.5.2. Product Strategy
19.1.17.5.3. Channel Strategy
20. Assumptions & Acronyms Used21. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Value (US$ million) Forecast by Region, 2017 to 2033
Table 2: Global Volume (Units) Forecast by Region, 2017 to 2033
Table 3: Global Value (US$ million) Forecast by Product, 2017 to 2033
Table 4: Global Volume (Units) Forecast by Product, 2017 to 2033
Table 5: Global Value (US$ million) Forecast by Raw Material, 2017 to 2033
Table 6: Global Volume (Units) Forecast by Raw Material, 2017 to 2033
Table 7: Global Value (US$ million) Forecast by Indication, 2017 to 2033
Table 8: Global Volume (Units) Forecast by Indication, 2017 to 2033
Table 9: Global Value (US$ million) Forecast by End User, 2017 to 2033
Table 10: Global Volume (Units) Forecast by End User, 2017 to 2033
Table 11: North America Value (US$ million) Forecast by Country, 2017 to 2033
Table 12: North America Volume (Units) Forecast by Country, 2017 to 2033
Table 13: North America Value (US$ million) Forecast by Product, 2017 to 2033
Table 14: North America Volume (Units) Forecast by Product, 2017 to 2033
Table 15: North America Value (US$ million) Forecast by Raw Material, 2017 to 2033
Table 16: North America Volume (Units) Forecast by Raw Material, 2017 to 2033
Table 17: North America Value (US$ million) Forecast by Indication, 2017 to 2033
Table 18: North America Volume (Units) Forecast by Indication, 2017 to 2033
Table 19: North America Value (US$ million) Forecast by End User, 2017 to 2033
Table 20: North America Volume (Units) Forecast by End User, 2017 to 2033
Table 21: Latin America Value (US$ million) Forecast by Country, 2017 to 2033
Table 22: Latin America Volume (Units) Forecast by Country, 2017 to 2033
Table 23: Latin America Value (US$ million) Forecast by Product, 2017 to 2033
Table 24: Latin America Volume (Units) Forecast by Product, 2017 to 2033
Table 25: Latin America Value (US$ million) Forecast by Raw Material, 2017 to 2033
Table 26: Latin America Volume (Units) Forecast by Raw Material, 2017 to 2033
Table 27: Latin America Value (US$ million) Forecast by Indication, 2017 to 2033
Table 28: Latin America Volume (Units) Forecast by Indication, 2017 to 2033
Table 29: Latin America Value (US$ million) Forecast by End User, 2017 to 2033
Table 30: Latin America Volume (Units) Forecast by End User, 2017 to 2033
Table 31: Eastern Europe Value (US$ million) Forecast by Country, 2017 to 2033
Table 32: Eastern Europe Volume (Units) Forecast by Country, 2017 to 2033
Table 33: Eastern Europe Value (US$ million) Forecast by Product, 2017 to 2033
Table 34: Eastern Europe Volume (Units) Forecast by Product, 2017 to 2033
Table 35: Eastern Europe Value (US$ million) Forecast by Raw Material, 2017 to 2033
Table 36: Eastern Europe Volume (Units) Forecast by Raw Material, 2017 to 2033
Table 37: Eastern Europe Value (US$ million) Forecast by Indication, 2017 to 2033
Table 38: Eastern Europe Volume (Units) Forecast by Indication, 2017 to 2033
Table 39: Eastern Europe Value (US$ million) Forecast by End User, 2017 to 2033
Table 40: Eastern Europe Volume (Units) Forecast by End User, 2017 to 2033
Table 41: Western Europe Value (US$ million) Forecast by Country, 2017 to 2033
Table 42: Western Europe Volume (Units) Forecast by Country, 2017 to 2033
Table 43: Western Europe Value (US$ million) Forecast by Product, 2017 to 2033
Table 44: Western Europe Volume (Units) Forecast by Product, 2017 to 2033
Table 45: Western Europe Value (US$ million) Forecast by Raw Material, 2017 to 2033
Table 46: Western Europe Volume (Units) Forecast by Raw Material, 2017 to 2033
Table 47: Western Europe Value (US$ million) Forecast by Indication, 2017 to 2033
Table 48: Western Europe Volume (Units) Forecast by Indication, 2017 to 2033
Table 49: Western Europe Value (US$ million) Forecast by End User, 2017 to 2033
Table 50: Western Europe Volume (Units) Forecast by End User, 2017 to 2033
Table 51: APEJ Value (US$ million) Forecast by Country, 2017 to 2033
Table 52: APEJ Volume (Units) Forecast by Country, 2017 to 2033
Table 53: APEJ Value (US$ million) Forecast by Product, 2017 to 2033
Table 54: APEJ Volume (Units) Forecast by Product, 2017 to 2033
Table 55: APEJ Value (US$ million) Forecast by Raw Material, 2017 to 2033
Table 56: APEJ Volume (Units) Forecast by Raw Material, 2017 to 2033
Table 57: APEJ Value (US$ million) Forecast by Indication, 2017 to 2033
Table 58: APEJ Volume (Units) Forecast by Indication, 2017 to 2033
Table 59: APEJ Value (US$ million) Forecast by End User, 2017 to 2033
Table 60: APEJ Volume (Units) Forecast by End User, 2017 to 2033
Table 61: Japan Value (US$ million) Forecast by Country, 2017 to 2033
Table 62: Japan Volume (Units) Forecast by Country, 2017 to 2033
Table 63: Japan Value (US$ million) Forecast by Product, 2017 to 2033
Table 64: Japan Volume (Units) Forecast by Product, 2017 to 2033
Table 65: Japan Value (US$ million) Forecast by Raw Material, 2017 to 2033
Table 66: Japan Volume (Units) Forecast by Raw Material, 2017 to 2033
Table 67: Japan Value (US$ million) Forecast by Indication, 2017 to 2033
Table 68: Japan Volume (Units) Forecast by Indication, 2017 to 2033
Table 69: Japan Value (US$ million) Forecast by End User, 2017 to 2033
Table 70: Japan Volume (Units) Forecast by End User, 2017 to 2033
Table 71: MEA Value (US$ million) Forecast by Country, 2017 to 2033
Table 72: MEA Volume (Units) Forecast by Country, 2017 to 2033
Table 73: MEA Value (US$ million) Forecast by Product, 2017 to 2033
Table 74: MEA Volume (Units) Forecast by Product, 2017 to 2033
Table 75: MEA Value (US$ million) Forecast by Raw Material, 2017 to 2033
Table 76: MEA Volume (Units) Forecast by Raw Material, 2017 to 2033
Table 77: MEA Value (US$ million) Forecast by Indication, 2017 to 2033
Table 78: MEA Volume (Units) Forecast by Indication, 2017 to 2033
Table 79: MEA Value (US$ million) Forecast by End User, 2017 to 2033
Table 80: MEA Volume (Units) Forecast by End User, 2017 to 2033
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Value (US$ million) by Product, 2023 to 2033
Figure 2: Global Value (US$ million) by Raw Material, 2023 to 2033
Figure 3: Global Value (US$ million) by Indication, 2023 to 2033
Figure 4: Global Value (US$ million) by End User, 2023 to 2033
Figure 5: Global Value (US$ million) by Region, 2023 to 2033
Figure 6: Global Value (US$ million) Analysis by Region, 2017 to 2033
Figure 7: Global Volume (Units) Analysis by Region, 2017 to 2033
Figure 8: Global Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 9: Global Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 10: Global Value (US$ million) Analysis by Product, 2017 to 2033
Figure 11: Global Volume (Units) Analysis by Product, 2017 to 2033
Figure 12: Global Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 13: Global Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 14: Global Value (US$ million) Analysis by Raw Material, 2017 to 2033
Figure 15: Global Volume (Units) Analysis by Raw Material, 2017 to 2033
Figure 16: Global Value Share (%) and BPS Analysis by Raw Material, 2023 to 2033
Figure 17: Global Y-o-Y Growth (%) Projections by Raw Material, 2023 to 2033
Figure 18: Global Value (US$ million) Analysis by Indication, 2017 to 2033
Figure 19: Global Volume (Units) Analysis by Indication, 2017 to 2033
Figure 20: Global Value Share (%) and BPS Analysis by Indication, 2023 to 2033
Figure 21: Global Y-o-Y Growth (%) Projections by Indication, 2023 to 2033
Figure 22: Global Value (US$ million) Analysis by End User, 2017 to 2033
Figure 23: Global Volume (Units) Analysis by End User, 2017 to 2033
Figure 24: Global Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 25: Global Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 26: Global Attractiveness by Product, 2023 to 2033
Figure 27: Global Attractiveness by Raw Material, 2023 to 2033
Figure 28: Global Attractiveness by Indication, 2023 to 2033
Figure 29: Global Attractiveness by End User, 2023 to 2033
Figure 30: Global Attractiveness by Region, 2023 to 2033
Figure 31: North America Value (US$ million) by Product, 2023 to 2033
Figure 32: North America Value (US$ million) by Raw Material, 2023 to 2033
Figure 33: North America Value (US$ million) by Indication, 2023 to 2033
Figure 34: North America Value (US$ million) by End User, 2023 to 2033
Figure 35: North America Value (US$ million) by Country, 2023 to 2033
Figure 36: North America Value (US$ million) Analysis by Country, 2017 to 2033
Figure 37: North America Volume (Units) Analysis by Country, 2017 to 2033
Figure 38: North America Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 39: North America Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 40: North America Value (US$ million) Analysis by Product, 2017 to 2033
Figure 41: North America Volume (Units) Analysis by Product, 2017 to 2033
Figure 42: North America Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 43: North America Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 44: North America Value (US$ million) Analysis by Raw Material, 2017 to 2033
Figure 45: North America Volume (Units) Analysis by Raw Material, 2017 to 2033
Figure 46: North America Value Share (%) and BPS Analysis by Raw Material, 2023 to 2033
Figure 47: North America Y-o-Y Growth (%) Projections by Raw Material, 2023 to 2033
Figure 48: North America Value (US$ million) Analysis by Indication, 2017 to 2033
Figure 49: North America Volume (Units) Analysis by Indication, 2017 to 2033
Figure 50: North America Value Share (%) and BPS Analysis by Indication, 2023 to 2033
Figure 51: North America Y-o-Y Growth (%) Projections by Indication, 2023 to 2033
Figure 52: North America Value (US$ million) Analysis by End User, 2017 to 2033
Figure 53: North America Volume (Units) Analysis by End User, 2017 to 2033
Figure 54: North America Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 55: North America Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 56: North America Attractiveness by Product, 2023 to 2033
Figure 57: North America Attractiveness by Raw Material, 2023 to 2033
Figure 58: North America Attractiveness by Indication, 2023 to 2033
Figure 59: North America Attractiveness by End User, 2023 to 2033
Figure 60: North America Attractiveness by Country, 2023 to 2033
Figure 61: Latin America Value (US$ million) by Product, 2023 to 2033
Figure 62: Latin America Value (US$ million) by Raw Material, 2023 to 2033
Figure 63: Latin America Value (US$ million) by Indication, 2023 to 2033
Figure 64: Latin America Value (US$ million) by End User, 2023 to 2033
Figure 65: Latin America Value (US$ million) by Country, 2023 to 2033
Figure 66: Latin America Value (US$ million) Analysis by Country, 2017 to 2033
Figure 67: Latin America Volume (Units) Analysis by Country, 2017 to 2033
Figure 68: Latin America Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 69: Latin America Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 70: Latin America Value (US$ million) Analysis by Product, 2017 to 2033
Figure 71: Latin America Volume (Units) Analysis by Product, 2017 to 2033
Figure 72: Latin America Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 73: Latin America Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 74: Latin America Value (US$ million) Analysis by Raw Material, 2017 to 2033
Figure 75: Latin America Volume (Units) Analysis by Raw Material, 2017 to 2033
Figure 76: Latin America Value Share (%) and BPS Analysis by Raw Material, 2023 to 2033
Figure 77: Latin America Y-o-Y Growth (%) Projections by Raw Material, 2023 to 2033
Figure 78: Latin America Value (US$ million) Analysis by Indication, 2017 to 2033
Figure 79: Latin America Volume (Units) Analysis by Indication, 2017 to 2033
Figure 80: Latin America Value Share (%) and BPS Analysis by Indication, 2023 to 2033
Figure 81: Latin America Y-o-Y Growth (%) Projections by Indication, 2023 to 2033
Figure 82: Latin America Value (US$ million) Analysis by End User, 2017 to 2033
Figure 83: Latin America Volume (Units) Analysis by End User, 2017 to 2033
Figure 84: Latin America Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 85: Latin America Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 86: Latin America Attractiveness by Product, 2023 to 2033
Figure 87: Latin America Attractiveness by Raw Material, 2023 to 2033
Figure 88: Latin America Attractiveness by Indication, 2023 to 2033
Figure 89: Latin America Attractiveness by End User, 2023 to 2033
Figure 90: Latin America Attractiveness by Country, 2023 to 2033
Figure 91: Eastern Europe Value (US$ million) by Product, 2023 to 2033
Figure 92: Eastern Europe Value (US$ million) by Raw Material, 2023 to 2033
Figure 93: Eastern Europe Value (US$ million) by Indication, 2023 to 2033
Figure 94: Eastern Europe Value (US$ million) by End User, 2023 to 2033
Figure 95: Eastern Europe Value (US$ million) by Country, 2023 to 2033
Figure 96: Eastern Europe Value (US$ million) Analysis by Country, 2017 to 2033
Figure 97: Eastern Europe Volume (Units) Analysis by Country, 2017 to 2033
Figure 98: Eastern Europe Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 99: Eastern Europe Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 100: Eastern Europe Value (US$ million) Analysis by Product, 2017 to 2033
Figure 101: Eastern Europe Volume (Units) Analysis by Product, 2017 to 2033
Figure 102: Eastern Europe Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 103: Eastern Europe Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 104: Eastern Europe Value (US$ million) Analysis by Raw Material, 2017 to 2033
Figure 105: Eastern Europe Volume (Units) Analysis by Raw Material, 2017 to 2033
Figure 106: Eastern Europe Value Share (%) and BPS Analysis by Raw Material, 2023 to 2033
Figure 107: Eastern Europe Y-o-Y Growth (%) Projections by Raw Material, 2023 to 2033
Figure 108: Eastern Europe Value (US$ million) Analysis by Indication, 2017 to 2033
Figure 109: Eastern Europe Volume (Units) Analysis by Indication, 2017 to 2033
Figure 110: Eastern Europe Value Share (%) and BPS Analysis by Indication, 2023 to 2033
Figure 111: Eastern Europe Y-o-Y Growth (%) Projections by Indication, 2023 to 2033
Figure 112: Eastern Europe Value (US$ million) Analysis by End User, 2017 to 2033
Figure 113: Eastern Europe Volume (Units) Analysis by End User, 2017 to 2033
Figure 114: Eastern Europe Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 115: Eastern Europe Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 116: Eastern Europe Attractiveness by Product, 2023 to 2033
Figure 117: Eastern Europe Attractiveness by Raw Material, 2023 to 2033
Figure 118: Eastern Europe Attractiveness by Indication, 2023 to 2033
Figure 119: Eastern Europe Attractiveness by End User, 2023 to 2033
Figure 120: Eastern Europe Attractiveness by Country, 2023 to 2033
Figure 121: Western Europe Value (US$ million) by Product, 2023 to 2033
Figure 122: Western Europe Value (US$ million) by Raw Material, 2023 to 2033
Figure 123: Western Europe Value (US$ million) by Indication, 2023 to 2033
Figure 124: Western Europe Value (US$ million) by End User, 2023 to 2033
Figure 125: Western Europe Value (US$ million) by Country, 2023 to 2033
Figure 126: Western Europe Value (US$ million) Analysis by Country, 2017 to 2033
Figure 127: Western Europe Volume (Units) Analysis by Country, 2017 to 2033
Figure 128: Western Europe Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 129: Western Europe Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 130: Western Europe Value (US$ million) Analysis by Product, 2017 to 2033
Figure 131: Western Europe Volume (Units) Analysis by Product, 2017 to 2033
Figure 132: Western Europe Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 133: Western Europe Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 134: Western Europe Value (US$ million) Analysis by Raw Material, 2017 to 2033
Figure 135: Western Europe Volume (Units) Analysis by Raw Material, 2017 to 2033
Figure 136: Western Europe Value Share (%) and BPS Analysis by Raw Material, 2023 to 2033
Figure 137: Western Europe Y-o-Y Growth (%) Projections by Raw Material, 2023 to 2033
Figure 138: Western Europe Value (US$ million) Analysis by Indication, 2017 to 2033
Figure 139: Western Europe Volume (Units) Analysis by Indication, 2017 to 2033
Figure 140: Western Europe Value Share (%) and BPS Analysis by Indication, 2023 to 2033
Figure 141: Western Europe Y-o-Y Growth (%) Projections by Indication, 2023 to 2033
Figure 142: Western Europe Value (US$ million) Analysis by End User, 2017 to 2033
Figure 143: Western Europe Volume (Units) Analysis by End User, 2017 to 2033
Figure 144: Western Europe Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 145: Western Europe Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 146: Western Europe Attractiveness by Product, 2023 to 2033
Figure 147: Western Europe Attractiveness by Raw Material, 2023 to 2033
Figure 148: Western Europe Attractiveness by Indication, 2023 to 2033
Figure 149: Western Europe Attractiveness by End User, 2023 to 2033
Figure 150: Western Europe Attractiveness by Country, 2023 to 2033
Figure 151: APEJ Value (US$ million) by Product, 2023 to 2033
Figure 152: APEJ Value (US$ million) by Raw Material, 2023 to 2033
Figure 153: APEJ Value (US$ million) by Indication, 2023 to 2033
Figure 154: APEJ Value (US$ million) by End User, 2023 to 2033
Figure 155: APEJ Value (US$ million) by Country, 2023 to 2033
Figure 156: APEJ Value (US$ million) Analysis by Country, 2017 to 2033
Figure 157: APEJ Volume (Units) Analysis by Country, 2017 to 2033
Figure 158: APEJ Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 159: APEJ Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 160: APEJ Value (US$ million) Analysis by Product, 2017 to 2033
Figure 161: APEJ Volume (Units) Analysis by Product, 2017 to 2033
Figure 162: APEJ Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 163: APEJ Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 164: APEJ Value (US$ million) Analysis by Raw Material, 2017 to 2033
Figure 165: APEJ Volume (Units) Analysis by Raw Material, 2017 to 2033
Figure 166: APEJ Value Share (%) and BPS Analysis by Raw Material, 2023 to 2033
Figure 167: APEJ Y-o-Y Growth (%) Projections by Raw Material, 2023 to 2033
Figure 168: APEJ Value (US$ million) Analysis by Indication, 2017 to 2033
Figure 169: APEJ Volume (Units) Analysis by Indication, 2017 to 2033
Figure 170: APEJ Value Share (%) and BPS Analysis by Indication, 2023 to 2033
Figure 171: APEJ Y-o-Y Growth (%) Projections by Indication, 2023 to 2033
Figure 172: APEJ Value (US$ million) Analysis by End User, 2017 to 2033
Figure 173: APEJ Volume (Units) Analysis by End User, 2017 to 2033
Figure 174: APEJ Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 175: APEJ Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 176: APEJ Attractiveness by Product, 2023 to 2033
Figure 177: APEJ Attractiveness by Raw Material, 2023 to 2033
Figure 178: APEJ Attractiveness by Indication, 2023 to 2033
Figure 179: APEJ Attractiveness by End User, 2023 to 2033
Figure 180: APEJ Attractiveness by Country, 2023 to 2033
Figure 181: Japan Value (US$ million) by Product, 2023 to 2033
Figure 182: Japan Value (US$ million) by Raw Material, 2023 to 2033
Figure 183: Japan Value (US$ million) by Indication, 2023 to 2033
Figure 184: Japan Value (US$ million) by End User, 2023 to 2033
Figure 185: Japan Value (US$ million) by Country, 2023 to 2033
Figure 186: Japan Value (US$ million) Analysis by Country, 2017 to 2033
Figure 187: Japan Volume (Units) Analysis by Country, 2017 to 2033
Figure 188: Japan Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 189: Japan Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 190: Japan Value (US$ million) Analysis by Product, 2017 to 2033
Figure 191: Japan Volume (Units) Analysis by Product, 2017 to 2033
Figure 192: Japan Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 193: Japan Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 194: Japan Value (US$ million) Analysis by Raw Material, 2017 to 2033
Figure 195: Japan Volume (Units) Analysis by Raw Material, 2017 to 2033
Figure 196: Japan Value Share (%) and BPS Analysis by Raw Material, 2023 to 2033
Figure 197: Japan Y-o-Y Growth (%) Projections by Raw Material, 2023 to 2033
Figure 198: Japan Value (US$ million) Analysis by Indication, 2017 to 2033
Figure 199: Japan Volume (Units) Analysis by Indication, 2017 to 2033
Figure 200: Japan Value Share (%) and BPS Analysis by Indication, 2023 to 2033
Figure 201: Japan Y-o-Y Growth (%) Projections by Indication, 2023 to 2033
Figure 202: Japan Value (US$ million) Analysis by End User, 2017 to 2033
Figure 203: Japan Volume (Units) Analysis by End User, 2017 to 2033
Figure 204: Japan Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 205: Japan Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 206: Japan Attractiveness by Product, 2023 to 2033
Figure 207: Japan Attractiveness by Raw Material, 2023 to 2033
Figure 208: Japan Attractiveness by Indication, 2023 to 2033
Figure 209: Japan Attractiveness by End User, 2023 to 2033
Figure 210: Japan Attractiveness by Country, 2023 to 2033
Figure 211: MEA Value (US$ million) by Product, 2023 to 2033
Figure 212: MEA Value (US$ million) by Raw Material, 2023 to 2033
Figure 213: MEA Value (US$ million) by Indication, 2023 to 2033
Figure 214: MEA Value (US$ million) by End User, 2023 to 2033
Figure 215: MEA Value (US$ million) by Country, 2023 to 2033
Figure 216: MEA Value (US$ million) Analysis by Country, 2017 to 2033
Figure 217: MEA Volume (Units) Analysis by Country, 2017 to 2033
Figure 218: MEA Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 219: MEA Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 220: MEA Value (US$ million) Analysis by Product, 2017 to 2033
Figure 221: MEA Volume (Units) Analysis by Product, 2017 to 2033
Figure 222: MEA Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 223: MEA Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 224: MEA Value (US$ million) Analysis by Raw Material, 2017 to 2033
Figure 225: MEA Volume (Units) Analysis by Raw Material, 2017 to 2033
Figure 226: MEA Value Share (%) and BPS Analysis by Raw Material, 2023 to 2033
Figure 227: MEA Y-o-Y Growth (%) Projections by Raw Material, 2023 to 2033
Figure 228: MEA Value (US$ million) Analysis by Indication, 2017 to 2033
Figure 229: MEA Volume (Units) Analysis by Indication, 2017 to 2033
Figure 230: MEA Value Share (%) and BPS Analysis by Indication, 2023 to 2033
Figure 231: MEA Y-o-Y Growth (%) Projections by Indication, 2023 to 2033
Figure 232: MEA Value (US$ million) Analysis by End User, 2017 to 2033
Figure 233: MEA Volume (Units) Analysis by End User, 2017 to 2033
Figure 234: MEA Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 235: MEA Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 236: MEA Attractiveness by Product, 2023 to 2033
Figure 237: MEA Attractiveness by Raw Material, 2023 to 2033
Figure 238: MEA Attractiveness by Indication, 2023 to 2033
Figure 239: MEA Attractiveness by End User, 2023 to 2033
Figure 240: MEA Attractiveness by Country, 2023 to 2033
